Novozymes A/S (OTCMKTS:NVZMY) Shares Pass Below Two Hundred Day Moving Average – Should You Sell?

Shares of Novozymes A/S (OTCMKTS:NVZMY) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $62.28 and traded as low as $55.74. Novozymes A/S shares last traded at $56.00, with a volume of 16,126 shares traded.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on NVZMY shares. Barclays raised Novozymes A/S to a “strong-buy” rating in a research report on Monday, November 18th. Citigroup lowered Novozymes A/S from a “neutral” rating to a “sell” rating in a research report on Thursday, October 17th.

Novozymes A/S Stock Down 2.1 %

The stock’s fifty day simple moving average is $57.15 and its two-hundred day simple moving average is $62.28. The firm has a market cap of $26.22 billion, a PE ratio of 35.44, a PEG ratio of 3.87 and a beta of 0.87.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.